Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-796P is a member of the U6 small nuclear RNA pseudogene family. Pseudogenes like RNU6-796P are DNA sequences that resemble functional genes but lack the ability to encode functional proteins or RNAs due to mutations, deletions, or insertions. U6 small nuclear RNAs are components of the spliceosome, crucial for mRNA splicing, but pseudogenes of U6 like RNU6-796P are considered non-functional remnants in the genome[1][4][7]. Most U6 pseudogenes do not produce functional RNA and have no established biological role, therapeutic value, or disease association specific to their sequence. In rare contexts, pseudogenes may regulate gene expression through various RNA-mediated regulatory mechanisms, but there is no evidence for RNU6-796P having such activity[2][7]. Key points: - RNU6-796P is a non-coding RNA pseudogene, not a protein or functional RNA[1][4]. - It is not considered a therapeutic drug target; there are no drugs, biomarkers, or clinical safety considerations associated with it[1][4]. - The name is accurate and standardized in current gene databases, but as a pseudogene, it does **not** fulfill the requirements of a classical drug/receptor/enzyme target[1][4]. - The only relevant molecular classification is "Other" (pseudogene)[1][4]. - No alias beyond RNU6-796P and its descriptive name. - No specific biological function, disease linkage, or pharmacological relevance applies to RNU6-796P[1][4][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 796, pseudogene (RNU6-796P).